Senrebotase

DB12626InvestigationalProtein Based Therapies

Senrebotase has been used in trials studying the treatment of Neuralgia, Postherpetic and Urinary Bladder, Overactive.

Code names
AGN-214868

Resolves to

Compound
UNII8SQP8A30GGCAS1290102-81-6

What you can answer from here — as of February 21, 2021

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Senrebotase, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In